发明名称 |
ADAMANTYL PYRROLIDIN-2-ONE DERIVATIVES AS 11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITORS |
摘要 |
<p>The N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein n is 1 or 2; M represents a direct bond or a C1-3alkyl linker optionally substituted with one or two substituents selected from C1-4alkyl, C1-3alkyloxy-C1-4alkyl-, hydroxy-C1-4alkyl-, hydroxy, C1-3alkyloxy- or phenyl-C1-4alkyl-; R<1> and R<2> each independently represent hydrogen, halo, cyano, hydroxy, Cl-4alkyl optionally substituted with halo, C1-4alkyloxy- optionally substituted with one or where possible two or three substituents selected from hydroxy, Ar<1> and halo ; R<3 >represents hydrogen, halo, C1-4alkyl, C1-4alkyloxy-, cyano or hydroxy; R<4> represents hydrogen, halo, Cl-4alkyl, hydroxy, cyano or C1-4alkyloxy- optionally substituted with one or where possible two or three substituents selected from hydroxy and halo; R<5> represents hydrogen, C1-4alkyl or Ar<2>-C1-4alkyl-; R<6> represents hydrogen, hydroxy, halo, C1-4alkyl or C1-4alkyoxy-; R<7> represents hydrogen or R<7> and R<5> taken together with the carbon atom to which they are attached from a -C2-alkyl- linker; Ar<1> and Ar<2> each independently represent phenyl or naphtyl wherein said phenyl and naphtyl are optionally substituted with C1-4alkyl, C1-4alkyloxy-, or phenyl-C1-4alkyl.</p> |
申请公布号 |
WO2005108361(A1) |
申请公布日期 |
2005.11.17 |
申请号 |
WO2005EP51970 |
申请日期 |
2005.04.29 |
申请人 |
JANSSEN PHARMACEUTICA N.V.;JAROSKOVA, LIBUSE;LINDERS, JOANNES, THEODORUS, MARIA;BUYCK, CHRISTOPHE, FRANCIS, ROBERT, NESTOR;VAN DER VEKEN, LOUIS, JOZEF, ELISABETH |
发明人 |
JAROSKOVA, LIBUSE;LINDERS, JOANNES, THEODORUS, MARIA;BUYCK, CHRISTOPHE, FRANCIS, ROBERT, NESTOR;VAN DER VEKEN, LOUIS, JOZEF, ELISABETH |
分类号 |
C07D207/26;C07D207/267;C07D211/76;C07D453/06;(IPC1-7):C07D207/26;A61K31/402 |
主分类号 |
C07D207/26 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|